-
Dabigatran Etexilate: Review of Oral Thrombin Inhibition
2026-09-24
Blommel and Blommel review dabigatran etexilate as an orally administered prodrug of a reversible, direct thrombin inhibitor, emphasizing its predictable anticoagulant effects and the clinical settings in which it had shown efficacy. The review’s practical contribution is to connect mechanism and pharmacokinetics with potential advantages over vitamin K antagonists and low-molecular-weight heparins, while underscoring bleeding risk and the need to account for renal function.
-
Repaglinide: Interpreting Metabolic Effects in Research
2026-09-24
Repaglinide is a short-acting insulin secretagogue whose effects should be interpreted in the context of pancreatic beta-cell physiology—not assumed to explain DNA repair or leukemia biology. This article connects its established pharmacology with a recent study of energy stress in AML and outlines practical controls for keeping those experimental questions distinct.
-
Systemic PTEN mRNA Delivery Reverses Trastuzumab Resistance
2026-09-23
The study describes a tumor-microenvironment-responsive nanoparticle designed to deliver PTEN mRNA systemically and restore a tumor-suppressive signal in trastuzumab-resistant HER2-positive breast cancer. Its central finding is that PTEN restoration can inhibit PI3K/Akt signaling and improve the response to trastuzumab in the reported models, while the delivery strategy addresses barriers to getting mRNA into tumor cells.
-
Erlotinib Workflows for EGFR–SCUBE3 Research
2026-09-23
Build reproducible EGFR target-engagement, proliferation, and apoptosis assays with Erlotinib, also known as NSC 718781. The workflow positions EGFR inhibition as a mechanistic comparator for SCUBE3-driven signaling, therapy resistance, and immune-suppressive phenotypes rather than treating Erlotinib as a direct SCUBE3 inhibitor.
-
EdU Imaging Kits (HF594): Practical Protocol Guide
2026-09-22
EdU Imaging Kits (HF594) measure S-phase DNA synthesis through 5-ethynyl-2’-deoxyuridine incorporation and HyperFluor™ 594 click-chemistry detection. This guide covers fixed-cell fluorescence microscopy and flow cytometry workflows, while clarifying that the assay is not a direct measure of all proliferation events or a live-cell imaging method.
-
KCNE4-Dependent Modulation of Kv1.3 Pharmacology
2026-09-22
The reference study shows that the auxiliary subunit KCNE4 changes Kv1.3 pharmacology mainly by slowing intracellular Psora-4 inhibition rather than by changing blocker affinity. This finding makes channel-subunit composition and inhibition kinetics important variables in research on T cell Ca2+ signaling and immunomodulator targeting Kv1.3.
-
APEX-RNA-MS Maps RNA Modifications in Condensates
2026-09-21
Seo, Dhingani, and Kleiner introduce APEX-RNA-MS, a workflow that combines APEX2 proximity labeling with nucleoside LC-MS to quantify modified RNA in defined protein neighborhoods. The study links m6A and m5C to DNA damage foci and shows that cytosolic tRNAs accumulate with G3BP1 in arsenite-induced stress granules.
-
5-Aza-2′-Deoxycytidine Toxicology in Mice
2026-09-21
Momparler and Frith established a route-relevant mouse toxicology framework for 5-Aza-2′-deoxycytidine, combining continuous intravenous exposure, sex-specific lethality estimates, and time-resolved pathology. The study identified reversible marrow, intestinal, thymic, and testicular lesions near the lethal range, while also showing that leukopenia could persist well beyond other toxic effects.
-
Cas9 mRNA Precision: From Cap to Control
2026-09-20
Precision genome editing depends on more than guide design and nuclease fidelity. This thought-leadership article examines how Cas9 mRNA architecture, innate immune sensing, translation, intracellular trafficking, and exposure duration shape experimental and translational decisions. It connects the design of EZ Cap™ Cas9 mRNA (m1Ψ) with evidence that nuclear export can regulate Cas9 activity, while separating product specifications from independently demonstrated biological performance.
-
Demethyleneberberine in Con A–Induced Autoimmune Hepatitis
2026-09-19
The reference study shows that Demethyleneberberine (DMB) protects mice from concanavalin A-induced autoimmune hepatitis by reducing inflammatory injury, immune-cell infiltration, oxidative stress, and activation of NF-κB and MAPK signaling. Its integrated serum, histological, cytokine, and pathway analyses provide a useful framework for evaluating DMB as an anti-autoimmune hepatitis agent while leaving questions about chronic disease, pharmacokinetics, and clinical translation unresolved.
-
PEG 400 Improves Quercetin Bioavailability
2026-09-18
A 2026 reference study shows that PEG 400 substantially increases oral quercetin and quercetin-3-O-β-D-glucuronide exposure while enhancing anti-inflammatory activity in rats. By combining pharmacokinetics, spatial mass spectrometry imaging, enzyme models, transporter assays, and paw-edema testing, the work links formulation effects with UGT1A9, BCRP, and MRP2 regulation.
-
GTP Solution (100 mM) for mRNA Workflows
2026-09-18
GTP Solution is a high-purity Guanosine-5'-triphosphate stock for controlled enzymatic RNA synthesis and signal transduction research. Its defined concentration, near-neutral pH, nuclease-free specification, and frozen-storage requirements support reproducible molecular biology workflows, but the reagent is not itself a p21 therapy or lipid nanoparticle formulation.
-
SARS-CoV-2 N Protein, GADD34, and Atypical Foci
2026-09-17
A 2024 Molecules study identifies a stress-granule-linked mechanism by which SARS-CoV-2 nucleocapsid protein suppresses GADD34-dependent innate immunity. The work connects GADD34 mRNA sequestration in atypical N-positive foci with impaired IRF3 nuclear localization, offering a mechanistic framework for interpreting viral immune evasion and for designing related stress-granule assays.
-
SARS-CoV-2 N Protein Rewires GADD34 Antiviral Signaling
2026-09-17
Liu et al. identify a mechanism in which SARS-CoV-2 nucleocapsid protein redirects GADD34 mRNA into atypical N+/G3BP1+ foci, weakening IRF3-dependent interferon production. The study links stress-granule remodeling to viral immune evasion and provides a mechanistic framework for evaluating host–virus RNA stress responses.
-
Electroporation for CRISPR Editing in Mouse Zygotes
2026-09-16
Hashimoto and Takemoto established electroporation as a scalable alternative to microinjection for delivering CRISPR/Cas9 RNA into mouse zygotes with an intact zona pellucida. Their optimized workflow supported both targeted disruption and ssODN-mediated knock-in, providing a practical foundation for higher-throughput genome editing in mouse embryos.